Trademark: 79317755
Status Date
Tuesday, September 27, 2022
Registration Number
6854609
Registration Date
Tuesday, September 27, 2022
Filing Date
Tuesday, February 9, 2021
Published for Opposition
Tuesday, July 12, 2022
9 Recorded computer software for supporting diagnostic testing for and determination of risk stratification of prostate cancer; recorded computer program for analysing, displaying, modeling, and stratifying data from diagnostic blood tests and clinical data; instruments for diagnosis for scientific use, namely, diagnostic apparatus for testing biological specimens; parts and fittings for all the aforesaid goods included in this class
5 Medical and veterinary preparations and articles, namely, diagnostic blood test for risk stratification of prostate cancer; diagnostic preparations and materials for medical use; reagents for use in diagnostic tests for medical purposes; diagnostic testing materials for medical use, namely, medical diagnostic reagents and medical diagnostic assays for testing body fluids for determining the presence of certain protein and genetic markers; diagnostic test materials for prostate cancer, namely, medical diagnostic reagents and medical diagnostic assays for testing body fluids for medical determination of risk stratification of prostate cancer; diagnostic preparations for medical purposes; diagnostic agents for medical use
44 Human healthcare services; medical services; execution of medical tests for diagnostic or treatment purposes; medical diagnostic services, namely, medical testing for diagnostic or treatment purposes; health care services, namely, providing diagnostic tests for prostate cancer; online services relating to medical and diagnostic prostate cancer tests in the nature of medical and health care services related to prostate cancer testing through online services, providing online services in the nature of website featuring information, advice, and consultation related to prostate cancer diagnostic testing; prostate cancer screening services; execution of prostate cancer tests for diagnostic or treatment purposes; health care services, namely, providing prostate cancer diagnostics; medical testing services relating to prostate cancer; taking of blood samples; services for the testing of blood; performing diagnosis of diseases; medical testing for diagnostic or treatment purposes; medical services for the diagnosis of conditions of the human body; medical analysis for the diagnosis and treatment of persons; medical testing services relating to the diagnosis and treatment of disease; medical analysis services for the diagnosis of cancer; medical analysis services for cancer diagnosis and prognosis; providing information relating to medical results and diagnostic tests, namely, prostate cancer tests; providing information relating to medical test results; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; medical laboratory services for the analysis of samples and blood samples taken from patients; rental of equipment for human healthcare; advice, consultancy and information relating to the aforesaid, included in this class
10 Medical and veterinary apparatus and instruments, namely, apparatus to perform a diagnostic test for risk stratification of prostate cancer; diagnostic, examination and monitoring equipment for medical use, namely apparatus for medical diagnostic testing and risk stratification in the field of prostate cancer; testing apparatus for medical purposes, namely, human blood and specimen testing apparatus; medical test instruments for prostate cancer; testing probes for medical diagnostic purposes; testing instruments for medical diagnostic purposes; tools for medical diagnostics, namely, medical diagnostic apparatuses for testing for and forecasting risk of prostate cancer; apparatus for carrying-out diagnostic tests for medical purposes, namely, medical diagnostic apparatuses for testing of human body fluids
42 IT programming services in the nature of computer programming; software development, programming and implementation; web site hosting services; Software as a service (SAAS) services featuring software for diagnostic medical testing and related data analysis; rental of computer software; providing temporary use of on-line non-downloadable software for diagnostic medical testing and related data analysis; scientific and technology services, namely, diagnostic medical testing services for others for scientific research purposes; chemical and pharmaceutical research; medical and pharmacological research services; conducting clinical trials for others; scientific research for medical purposes in the area of cancerous diseases; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; providing information on clinical studies via an interactive website; medical and scientific laboratory services; advice, consultancy and information relating to the aforesaid, included in this class
STOCKHOLME; STOCKHOLM 3, STOCKHOLMTHREE; STOCKHOLM THREE
Sep 9, 2023
New Representative At Ib Received
Feb 14, 2023
Final Decision Transaction Processed By Ib
Jan 23, 2023
Final Disposition Notice Sent To Ib
Jan 23, 2023
Final Disposition Processed
Dec 27, 2022
Final Disposition Notice Created, To Be Sent To Ib
Sep 27, 2022
Notice Of Registration Confirmation Emailed
Sep 27, 2022
Registered-Principal Register
Jul 18, 2022
Notification Processed By Ib
Jul 12, 2022
Official Gazette Publication Confirmation E-Mailed
Jul 12, 2022
Published For Opposition
Jun 29, 2022
Notification Of Possible Opposition Sent To Ib
Jun 29, 2022
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Jun 22, 2022
Notification Of Notice Of Publication E-Mailed
Jun 7, 2022
Approved For Pub - Principal Register
Jun 6, 2022
Teas/Email Correspondence Entered
Jun 6, 2022
Correspondence Received In Law Office
Jun 6, 2022
Teas Response To Office Action Received
Jan 21, 2022
New Representative At Ib Received
Dec 26, 2021
Refusal Processed By Ib
Dec 8, 2021
Non-Final Action Mailed - Refusal Sent To Ib
Dec 8, 2021
Refusal Processed By Mpu
Nov 9, 2021
Non-Final Action (Ib Refusal) Prepared For Review
Nov 8, 2021
Non-Final Action Written
Sep 3, 2021
Assigned To Examiner
Aug 20, 2021
Application Filing Receipt Mailed
Aug 16, 2021
New Application Office Supplied Data Entered
Aug 12, 2021
Sn Assigned For Sect 66a Appl From Ib
Trademark Alertz updated from USPTO on 2030-01-24
